Skin Lightening and Evenness Effects of Oral Supplementation With S‐Acetyl Glutathione in Comparison With Reduced Glutathione: A Double‐Blind, Placebo‐Controlled Clinical Trial
Journal of Cosmetic Dermatology · 2026-10 · 25 (10)
DOI: 10.1111/jocd.71223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 14.10.2026. Verfasst von Arie Kusumawardani und 4 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Sebelas Maret.
Abstract (Originalsprache)
S‐Acetyl Glutathione (SAG) is an advanced glutathione derivative designed to improve stability, bioavailability, and efficacy in skin‐lightening applications. Unlike conventional glutathione formulations, SAG offers great cellular uptake and antioxidative properties, making it a promising candidate for managing hyperpigmentation disorders.
Purpose
This randomized, double‐blind, placebo‐controlled multicenter study evaluates the efficacy and safety of SAG compared to reduced glutathione and placebo in reducing hyperpigmentation, enhancing skin health, and improving patient's satisfaction and physician's assessment. Patients and Methods A total of 90 participants with Fitzpatrick skin Type IV and V were randomly assigned to receive oral crystalline form of SAG (200 mg/day), reduced glutathione (500 mg/day), or placebo. The primary outcome was the change in melanin index from Week 0 to Week 12, measured via Mexameter readings. Secondary outcomes included the change of transepidermal water loss (TEWL), pigmentation changes measured via facial skin analyzer, patient's and physician's satisfaction assessments. Exploratory outcomes included change in total glutathione (GSH).
Results
SAG demonstrated better melanin index reduction compared to reduced glutathione and placebo. SAG showed faster reduction in melanin index compared to reduced glutathione and placebo statistically significantly. TEWL showed significant differences at Week 8 and Week 12 between groups. A significant results confirmed in patient's and physician's satisfaction assessment. However no significant pigmentation reduction in all groups, and no statistical significant different in GSH level between groups.
Conclusion
SAG show faster acceleration in reducing melanin index, thus this helps patients with hyperpigmentation received a better result in shorter period, both SAG and reduced glutathione also enhancing skin barrier function, and improving overall skin aesthetics, though SAG has clinically proven, no significancy in pigmentation reduction should be noted. Further studies are recommended to assess its long‐term safety and efficacy in diverse populations.
Förderung
- Universitas Sebelas Maret
Zitieren
APA
Kusumawardani, A., Norawati, L., Veronica, S., Murasmita, A., & Rosmarwati, E. (2026). Skin Lightening and Evenness Effects of Oral Supplementation With S‐Acetyl Glutathione in Comparison With Reduced Glutathione: A Double‐Blind, Placebo‐Controlled Clinical Trial. Journal of Cosmetic Dermatology, 25(10). https://doi.org/10.1111/jocd.71223
Vancouver
Kusumawardani A, Norawati L, Veronica S, Murasmita A, Rosmarwati E. Skin Lightening and Evenness Effects of Oral Supplementation With S‐Acetyl Glutathione in Comparison With Reduced Glutathione: A Double‐Blind, Placebo‐Controlled Clinical Trial. Journal of Cosmetic Dermatology. 2026;25(10). doi:10.1111/jocd.71223
BibTeX
@article{Kusumawardani2026,
author = {Kusumawardani, Arie and Norawati, Lilik and Veronica, Silvia and Murasmita, Alamanda and Rosmarwati, Ervina},
title = {Skin Lightening and Evenness Effects of Oral Supplementation With S‐Acetyl Glutathione in Comparison With Reduced Glutathione: A Double‐Blind, Placebo‐Controlled Clinical Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {10},
doi = {10.1111/jocd.71223}
}
EUVIMED